asco2003

Note: Print this page for easy reference

Cancer Treatment Updates:

Highlights from ASCO 2003

NOTE: The broadcast schedule for this program is complete.

If you have questions regarding your educational credit:

Contact the sponsor via e-mail or telephone 609-921-6622.

If you would like to obtain a copy of the certified monograph or the certified videotape:

Please send an e-mail to the publisher.

Financial support for this program is provided by an educational grant from Ortho Biotech Products, L. P.

Moderator:

Kandice Kottke-Marchant, MD, PhD

The Cleveland Clinic

Cleveland, OH

Faculty:

Corey J. Langer, MD: "Lung Cancer Treatment Updates"

Associate Professor, Department of Medicine

Temple University School of Medicine

Co-Director, Thoracic Oncology

Fox Chase Cancer Center

Philadelphia, PA

Robert Diasio, MD: "Colorectal Cancer Treatment Updates"

Professor of Medicine and Pharmacology

Associate Director, UAB Comprehensive Cancer Center

University of Alabama at Birmingham

Birmingham, AL

Peter G. Rose, MD: "Gynecological Cancer Treatment Updates"

Professor, Reproductive Biology and Oncology

Case Western Reserve University School of Medicine

Director, Divisions of Gynecologic Oncology

Metro Health Medical Center

Cleveland, OH

Clifford A. Hudis, MD: "Breast Cancer Treatment Updates"

Associate Professor of Clinical Medicine

Joan and Sanford I. Weill Medical College of Cornell University

Memorial Sloan-Kettering Cancer Center

New York, NY

This is a two-hour program which will be rebroadcast:

Live Broadcast:

Wednesday, June 18, 2003, 1 PM Eastern

(12 Noon Central, 11 AM Mountain, 10 AM Pacific)

Rebroadcast:

Thursday, June 26, 2002, 4 PM Eastern

(3 PM Central, 2 PM Mountain, 1 PM Pacific)

Accreditation:

Physicians: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the American Academy of CME, Inc. The American Academy of CME, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The American Academy of CME, Inc. designates this CME activity for a maximum of 2 hours in Category 1 credit toward the American Medical Association Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

Pharmacists: The American Academy of CME, Inc. is approved by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education. Completion of this program provides for 2 hour (0.2 CEU) of continuing education credit. Participants must sign-in and complete and submit a program evaluation form in order to receive CE. Statements of credit will be mailed four to six weeks following receipt of materials from your on-site moderator.. The program number for the June 18 live broadcast is 297-999-03-003-L01 and the June 26 rebroadcast is 297-999-03-002-H01.

Nurses: The American Academy of CME, Inc., (AACME) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation AACME designates this educational activity for a maximum of 2.4 contact hours. Each nurse should claim only those hours that he/she actually spent in the educational activity

Disclosure: It is the policy of AACME to ensure balance, independence, objectivity, and scientific rigor in all sponsored programs. All faculty participating in programs are expected to disclose to the program audiences any relationship with a manufacturer of any product or device discussed in their presentation.

Objectives: Upon completion of this activity the participants should be able to:

-Interpret key data from current clinical trials presented on lung, colorectal, gynecological, and breast cancers.

-Compare current and future directions of the evolving treatment of lung, colorectal, gynecological, and breast cancers.

-Describe the importance of drug interactions, pre-medications, and side effects of chemotherapy.

-Describe the quality of life issues in regard to compliance and use of chemo and radiation therapy.

Target Audience: The primary target audience for this program is medical oncologists, physicians, pharmacists, nurses and other clinicians involved in the care of patients with cancer.